Roman Navarro, MD | |
101 The City Dr S, Orange, CA 92868-3201 | |
(714) 456-7890 | |
Not Available |
Full Name | Roman Navarro |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 10 Years |
Location | 101 The City Dr S, Orange, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154734671 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | A140374 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Joseph Hospital | Orange, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Emergency Medicine Specialists Of Orange County | 0840185005 | 42 |
News Archive
Portico Healthnet, a non-profit agency working to reduce the number of people without coverage for health care services, has been awarded more than $988,000 by the U.S. Department of Health and Human Services (HHS) to launch the Minnesota Coalition for Kids Health Coverage, a partnership of community agencies from around the state, to identify and enroll uninsured children into the Medical Assistance and MinnesotaCare state health coverage safety net programs.
AstraZeneca (NYSE: AZN) today announced the results of a Phase III long-term safety and tolerability study of the once-daily 25mg dose of naloxegol, in patients with non-cancer pain and opioid-induced constipation (OIC).
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have shed new light on Ewing's sarcoma, an often deadly bone cancer that typically afflicts children and young adults. Their research shows that patients with poor outcomes have tumors with high levels of a protein known as GSTM4, which may suppress the effects of chemotherapy.
New research reported today in Paris at the Alzheimer's Association International Conference 2011 (AAIC 2011) offers insight on the global incidence and prevalence of mild cognitive impairment (MCI) – a condition involving problems with memory or another mental function severe enough to be noticeable to the affected person or to others but not serious enough to interfere with daily life.
Drug discovery scientists need to broaden their approaches to pharmaceutical research and development (R&D) and Medicinal Chemistry, to take advantage of untapped opportunities, says Torsten Hoffmann, Head Discovery Chemistry at F. Hoffmann La Roche, Basel, Switzerland. Chemical Biology allows room for innovation, but is often overlooked by scientists in the industry.
› Verified 4 days ago
Entity Name | Emergency Medicine Specialists Of Orange County |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740214733 PECOS PAC ID: 0840185005 Enrollment ID: O20040217000695 |
News Archive
Portico Healthnet, a non-profit agency working to reduce the number of people without coverage for health care services, has been awarded more than $988,000 by the U.S. Department of Health and Human Services (HHS) to launch the Minnesota Coalition for Kids Health Coverage, a partnership of community agencies from around the state, to identify and enroll uninsured children into the Medical Assistance and MinnesotaCare state health coverage safety net programs.
AstraZeneca (NYSE: AZN) today announced the results of a Phase III long-term safety and tolerability study of the once-daily 25mg dose of naloxegol, in patients with non-cancer pain and opioid-induced constipation (OIC).
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have shed new light on Ewing's sarcoma, an often deadly bone cancer that typically afflicts children and young adults. Their research shows that patients with poor outcomes have tumors with high levels of a protein known as GSTM4, which may suppress the effects of chemotherapy.
New research reported today in Paris at the Alzheimer's Association International Conference 2011 (AAIC 2011) offers insight on the global incidence and prevalence of mild cognitive impairment (MCI) – a condition involving problems with memory or another mental function severe enough to be noticeable to the affected person or to others but not serious enough to interfere with daily life.
Drug discovery scientists need to broaden their approaches to pharmaceutical research and development (R&D) and Medicinal Chemistry, to take advantage of untapped opportunities, says Torsten Hoffmann, Head Discovery Chemistry at F. Hoffmann La Roche, Basel, Switzerland. Chemical Biology allows room for innovation, but is often overlooked by scientists in the industry.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Roman Navarro, MD 1310 W Stewart Dr Ste 212, Orange, CA 92868-3837 Ph: (714) 543-8911 | Roman Navarro, MD 101 The City Dr S, Orange, CA 92868-3201 Ph: (714) 456-7890 |
News Archive
Portico Healthnet, a non-profit agency working to reduce the number of people without coverage for health care services, has been awarded more than $988,000 by the U.S. Department of Health and Human Services (HHS) to launch the Minnesota Coalition for Kids Health Coverage, a partnership of community agencies from around the state, to identify and enroll uninsured children into the Medical Assistance and MinnesotaCare state health coverage safety net programs.
AstraZeneca (NYSE: AZN) today announced the results of a Phase III long-term safety and tolerability study of the once-daily 25mg dose of naloxegol, in patients with non-cancer pain and opioid-induced constipation (OIC).
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have shed new light on Ewing's sarcoma, an often deadly bone cancer that typically afflicts children and young adults. Their research shows that patients with poor outcomes have tumors with high levels of a protein known as GSTM4, which may suppress the effects of chemotherapy.
New research reported today in Paris at the Alzheimer's Association International Conference 2011 (AAIC 2011) offers insight on the global incidence and prevalence of mild cognitive impairment (MCI) – a condition involving problems with memory or another mental function severe enough to be noticeable to the affected person or to others but not serious enough to interfere with daily life.
Drug discovery scientists need to broaden their approaches to pharmaceutical research and development (R&D) and Medicinal Chemistry, to take advantage of untapped opportunities, says Torsten Hoffmann, Head Discovery Chemistry at F. Hoffmann La Roche, Basel, Switzerland. Chemical Biology allows room for innovation, but is often overlooked by scientists in the industry.
› Verified 4 days ago
Joseph Villarreal, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Building 1a, Room 1009, Orange, CA 92868 Phone: 714-456-5239 | |
Scott Rudkin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-2986 | |
Joelle Reynard, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Building 1a, Room 1009, Orange, CA 92868 Phone: 714-456-5239 | |
Dr. Inna Shniter, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 W Stewart Dr, Orange, CA 92868 Phone: 714-771-8113 | |
John C Fox, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-2986 | |
Miss Shannon Louise Toohey, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 The City Drive South, Bldg 200 , Suite 710, Rt 128-01, Orange, CA 92868 Phone: 715-456-5239 | |
Wirachin Hoonpongsimanont, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-5705 |